Trial intelligence / Profile preview

Diluted nitrous oxide for sedation and analgesia during dental scaling

ChiCTR2400090261Phase 2Not yet recruiting

Sponsor
960th Hospital
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in periodontitis, gingivitis, Dentinal hypersensitivity (DH) and 1 more comparing Nitrous oxide/oxygen inhalation with Oxygen inhalation placebo (2 arms). Primary endpoints: Pain score (VAS) and Anxiety score (VAS-A). Planned start Sep 2024; status: not yet recruiting.

02

Drugs

nitrous oxide
03

Conditions

periodontitisgingivitisDentinal hypersensitivity (DH)Dental anxiety

Beyond the preview

Go deeper on ChiCTR2400090261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400090261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call